Trends in Survival Based on Treatment Modality in Non-Small Cell Lung Cancer Patients: A Population-Based Study

References

• International Agency for Research on Cancer (IARC). World cancer report. Lyon, France: IARC; 2014.
   Google Scholar
• Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian cancer statistics. Toronto (ON): Canadian Cancer Society; 2017.
   Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. doi:10.3322/caac.21254.
   PubMed Web of Science ®Google Scholar
• Walters S, Maringe C, Coleman MP, Peake MD, Butler J, Young N, et al. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007. Thorax. 2013;68(6):551–564. doi:10.1136/thoraxjnl-2012-202297.
   PubMed Web of Science ®Google Scholar
• Lewin G, Morissette K, Dickinson J, Bell N, Bacchus M, Singh H, et al. Recommendations on screening for lung cancer. CMAJ. 2016;188(6):425–432. doi:10.1503/cmaj.151421.
   PubMed Web of Science ®Google Scholar
• Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–594. doi:10.4065/83.5.584.
   PubMed Web of Science ®Google Scholar
• Canadian Cancer Society. Survival statistics for non–small cell lung cancer. Toronto, Canada: Canadian Cancer Society; 2018. [updated 2018]; Available from: http://www.cancer.ca/en/cancer-information/cancer-type/lung/prognosis-and-survival/non-small-cell-lung-cancer-survival-statistics/?region=on.
   Google Scholar
• Cancer Care Ontario. Ontario cancer registry. Toronto, Canada: Cancer Care Ontario; 2018. Available from: https://www.cancercareontario.ca/en/cancer-care-ontario/programs/data-research/ontario-cancer-registry.
   Google Scholar
• Parkin M, Samet J, Tyczynski JE, Shields P, Boffetta P, Caporaso N. Lung cancer epidemiology and etiology. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, editors. World health organization classification of tumours: pathology & genetics, tumours of the lung, pleura, thymus, and heart. Geneva, Switzerland: WHO Press; 2004.
   Google Scholar
• Qin J, Li G, Zhou J. Characteristics of elderly patients with COPD and newly diagnosed lung cancer, and factors associated with treatment decision. Int J Chron Obstruct Pulmon Dis. 2016;11:1515–1520. doi:10.2147/COPD.S104670.
   PubMed Web of Science ®Google Scholar
• Canadian Institute for Health Information. Canadian classification of health intervention. Ottawa, Ontario: Canadian Institute for Health Information; 2015. Available from: https://www.cihi.ca/en/cci_volume_three_2015_en.pdf.
   Google Scholar
• Statistics Canada. Canadian classification of diagnostic, therapeutic, and surgical procedures. Ottawa, Ontario: Statistics Canada; 1986.
   Google Scholar
• Booth CM, Li G, Zhang-Salomons J, Mackillop WJ. The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer. 2010;116(17):4160–4167. doi:10.1002/cncr.25427.
   PubMed Web of Science ®Google Scholar
• Ginsburg OM, Fischer HD, Shah BR, Lipscombe L, Fu L, Anderson GM, et al. A population-based study of ethnicity and breast cancer stage at diagnosis in Ontario. Curr Oncol. 2015;22(2):97–104. doi:10.3747/co.22.2359.
   PubMed Web of Science ®Google Scholar
• Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. Stata J. 2009;9(2):265–290. doi:10.1177/1536867X0900900206.
   Web of Science ®Google Scholar
• Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Statist Med. 2002;21(15):2175–2197. doi:10.1002/sim.1203.
   PubMed Web of Science ®Google Scholar
• Rutherford MJ, Dickman PW, Lambert PC. Comparison of methods for calculating relative survival in population-based studies. Cancer Epidemiol. 2012;36(1):16–21. doi:10.1016/j.canep.2011.05.010.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute; 2019. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms. doi:10.1093/jnci/29.6.1197.
   Google Scholar
• Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J, Chirieac LR, et al. Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(4):504–535. doi:10.6004/jnccn.2017.0050.
   PubMed Web of Science ®Google Scholar
• Little AG, Rusch VW, Bonner JA, Gaspar LE, Green MR, Webb WR, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg. 2005;80(6):2051–2056. doi:10.1016/j.athoracsur.2005.06.071.
   PubMed Web of Science ®Google Scholar
• Harichand-Herdt S, Ramalingam SS. Gender-associated differences in lung cancer: clinical characteristics and treatment outcomes in women. Semin Oncol. 2009;36(6):572–580. doi:10.1053/j.seminoncol.2009.10.007.
   PubMed Web of Science ®Google Scholar
• Tong BC, Kosinski AS, Burfeind WR, Onaitis MW, Berry MF, Harpole DH, et al. Sex differences in early outcomes after lung cancer resection: analysis of the society of thoracic surgeons general thoracic database. J Thorac Cardiovasc Surg. 2014;148(1):13–18. doi:10.1016/j.jtcvs.2014.03.012.
   PubMed Web of Science ®Google Scholar
• Senbaklavaci O. Lobar lung resection in elderly patients with non-small cell lung carcinoma: impact of chronic obstructive pulmonary disease on surgical outcome. Int Surg. 2014;99(4):319–324. doi:10.9738/INTSURG-D-14-00015.1.
   PubMed Web of Science ®Google Scholar
• Senbaklavaci O, Taspinar H, Hartert M, Ergun S, Keranen S, Vahl CF. Lobar lung resection in elderly patients with non-small cell lung carcinoma: impact of cardiac comorbidity on surgical outcome. Swiss Med Wkly. 2012;142w13742. doi:10.4414/smw.2012.13742.
   PubMed Web of Science ®Google Scholar
• Takamochi K, Oh S, Matsuoka J, Suzuki K. Risk factors for morbidity after pulmonary resection for lung cancer in younger and elderly patients. Interact Cardiovasc Thorac Surg. 2011;12(5):739–743. doi:10.1510/icvts.2010.254821.
   PubMed Web of Science ®Google Scholar
• Schneider BJ, Daly ME, Kennedy EB, Antonoff MB, Broderick S, Feldman J, et al. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: American society of clinical oncology endorsement of the American society for radiation oncology evidence-based guideline. J Clin Oncol. 2018;36(7):710–719. doi:10.1200/JCO.2017.74.9671.
   PubMed Web of Science ®Google Scholar
• Videtic GMM, Donington J, Giuliani M, Heinzerling J, Karas TZ, Kelsey CR, et al. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline. Pract Radiat Oncol. 2017;7(5):295–301. doi:10.1016/j.prro.2017.04.014.
   PubMed Web of Science ®Google Scholar
• Lund CR, Cao JQ, Liu M, Olson R, Halperin R, Schellenberg D. The distribution and patterns of practice of stereotactic ablative body radiotherapy in Canada. J Med Imaging Radiat Sci. 2014;45(1):8–15. doi:10.1016/j.jmir.2013.09.001.
   PubMedGoogle Scholar
• Sahgal A, Roberge D, Schellenberg D, Purdie TG, Swaminath A, Pantarotto J, et al. The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. Clin Oncol (R Coll Radiol). 2012;24(9):629–639. doi:10.1016/j.clon.2012.04.006.
   PubMedGoogle Scholar
• Shirvani SM, Jiang J, Chang JY, Welsh J, Likhacheva A, Buchholz TA, et al. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. JAMA Surg. 2014;149(12):1244–1253. doi:10.1001/jamasurg.2014.556.
   PubMed Web of Science ®Google Scholar
• Xia W, Yu X, Mao Q, Xia W, Wang A, Dong G, et al. Improvement of survival for non-small cell lung cancer over time. Onco Targets Ther. 2017;104295–4303. doi:10.2147/OTT.S145036.
   PubMedGoogle Scholar
• Toh CK, Ong WS, Lim WT, Tan DS, Ng QS, Kanesvaran R, et al. A decade of never-smokers among lung cancer patients-Increasing trend and improved survival. Clin Lung Cancer. 2018;19:e539–e550.
   PubMed Web of Science ®Google Scholar
• Cufari ME, Proli C, De Sousa P, Raubenheimer H, Al Sahaf M, Chavan H, et al. Increasing frequency of non-smoking lung cancer: presentation of patients with early disease to a tertiary institution in the UK. Eur J Cancer. 2017;8455–59. doi:10.1016/j.ejca.2017.06.031.
   PubMed Web of Science ®Google Scholar
• Bustamante Alvarez JG, González-Cao M, Karachaliou N, Santarpia M, Viteri S, Teixidó C, et al. Advances in immunotherapy for treatment of lung cancer. Cancer Biol Med. 2015;12(3):209–222. doi:10.7497/j.issn.2095-3941.2015.0032.
   PubMed Web of Science ®Google Scholar
• Alexiou C, Beggs D, Onyeaka P, Kotidis K, Ghosh S, Beggs L, et al. Pneumonectomy for stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival. Ann Thorac Surg. 2003;76(4):1023–1028. doi:10.1016/S0003-4975(03)00883-X.
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Aisner DL, Wood DE, Akerley W, Bauman J, Chang JY, et al. NCCN guidelines insights: non-small cell lung cancer, version 5. J Natl Compr Canc Netw. 2018;16(7):807–821.  doi:10.6004/jnccn.2018.0062.
   PubMed Web of Science ®Google Scholar
• Hartmann JT, Lipp HP. Toxicity of platinum compounds. Expert Opin Pharmacother. 2003;4(6):889–901. doi:10.1517/14656566.4.6.889.
   PubMed Web of Science ®Google Scholar
• Dickman PW, Lambert PC, Coviello E, Rutherford MJ. Estimating net survival in population-based cancer studies. Int J Cancer. 2013;133(2):519–521. doi:10.1002/ijc.28041.
   PubMed Web of Science ®Google Scholar